Sbrt Boost | List of Frontiers open access articles

Original Research

Published on 29 May 2020

Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer

in Radiation Oncology

Shih-Chang Wang
Wei-Chen Ting
Yun-Ching Chang
Ching-Chieh Yang
Li-Ching Lin
Hsiu-Wen Ho
Shou-Sheng Chu
Yu-Wei Lin

Frontiers in Oncology

doi 10.3389/fonc.2020.00814

5,748 views
9 citations

Original Research

Published on 31 Oct 2014

The Early Result of Whole Pelvic Radiotherapy and Stereotactic Body Radiotherapy Boost for High-Risk Localized Prostate Cancer

in Radiation Oncology

Yu-Wei Lin
Li-Ching Lin
Kuei-Li Lin

Frontiers in Oncology

doi 10.3389/fonc.2014.00278

7,954 views
38 citations

Original Research

Published on 21 Mar 2012

CyberKnife Boost for Patients with Cervical Cancer Unable to Undergo Brachytherapy

in Radiation Oncology

Jonathan Andrew Haas
Matthew R Witten
Owen Clancey
Karen Episcopia
Diane Accordino
Eva Chalas

Frontiers in Oncology

doi 10.3389/fonc.2012.00025

11,865 views
84 citations

Methods

Published on 26 Sep 2012

Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer

in Radiation Oncology

Jaroslaw T. Hepel
Justin Peter
Jessica R. Hiatt
Salil Patel
Oluwademilade Osibanjo
Howard Safran
Bruce Curran
Thomas DiPetrillo

Frontiers in Oncology

doi 10.3389/fonc.2012.00124

6,112 views
8 citations

Original Research

Published on 06 Feb 2024

High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation

in Radiation Oncology

Jonathan W. Lischalk
Meredith Akerman
Michael C. Repka
Astrid Sanchez
Christopher Mendez
Vianca F. Santos
Todd Carpenter
David Wise
Anthony Corcoran
Herbert Lepor

Frontiers in Oncology

doi 10.3389/fonc.2024.1325200

4,386 views
2 citations

Original Research

Published on 21 Oct 2014

IMRT with Stereotactic Body Radiotherapy Boost for High Risk Malignant Salivary Gland Malignancies: A Case Series

in Radiation Oncology

Sana D. Karam
Abdul Rashid
James W. Snider
Margaux Wooster
Shilpa Bhatia
Ann K. Jay
Kenneth Newkirk
Bruce Davidson
William K. Harter

Frontiers in Oncology

doi 10.3389/fonc.2014.00268

5,924 views
10 citations

Original Research

Published on 06 May 2016

Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience

in Radiation Oncology

Catherine Mercado
Marie-Adele Kress
Robyn A. Cyr
Leonard N. Chen
Thomas M. Yung
Elizabeth G. Bullock
Siyuan Lei
Brian T. Collins
Andrew N. Satinsky
K. William Harter

Frontiers in Oncology

doi 10.3389/fonc.2016.00114

6,404 views
32 citations

Original Research

Published on 23 Nov 2023

Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes

in Radiation Oncology

Michael Carrasquilla
Tamir Sholklapper
Abigail N. Pepin
Nicole Hodgins
Siyuan Lei
Abdul Rashid
Malika Danner
Alan Zwart
Grecia Bolanos
Marilyn Ayoob

Frontiers in Oncology

doi 10.3389/fonc.2023.1240939

3,868 views
5 citations

Clinical Trial

Published on 02 Apr 2019

Phase 2 Multicenter Study of Gantry-Based Stereotactic Radiotherapy Boost for Intermediate and High Risk Prostate Cancer (PROMETHEUS)

in Radiation Oncology

David Pryor
Mark Sidhom
Sankar Arumugam
Joseph Bucci
Sarah Gallagher
Joanne Smart
Melissa Grand
Peter Greer
Sarah Keats
Lee Wilton

Frontiers in Oncology

doi 10.3389/fonc.2019.00217

6,787 views
33 citations

Articles

Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer

The Early Result of Whole Pelvic Radiotherapy and Stereotactic Body Radiotherapy Boost for High-Risk Localized Prostate Cancer

CyberKnife Boost for Patients with Cervical Cancer Unable to Undergo Brachytherapy

Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer

High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation

IMRT with Stereotactic Body Radiotherapy Boost for High Risk Malignant Salivary Gland Malignancies: A Case Series

Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience

Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes

Phase 2 Multicenter Study of Gantry-Based Stereotactic Radiotherapy Boost for Intermediate and High Risk Prostate Cancer (PROMETHEUS)